Literature DB >> 28978601

Isolated cerebral mucormycosis caused by Rhizomucor pusillus.

Saira Farid1, Omar AbuSaleh1, Rachael Liesman2, Muhammad Rizwan Sohail1.   

Abstract

A 61-year-old man with relapsing chronic lymphocytic leukaemia, status post allogeneic stem cell transplant and multiple chemotherapy regimens presented to the emergency room after suffering a grand mal seizure. His evaluation revealed a 1.5-2 cm ring-enhancing left temporal lobe brain lesion on the CT scan. This brain lesion was resected and the histopathology revealed an invasive fungal organism resembling mucormycosis. Amplification and sequencing of the 28S ribosomal RNA gene identified the organism as Rhizomucor pusillus The patient was treated with liposomal amphotericin B 5 mg/kg every 24 hours for 4 weeks, and then was transitioned to oral posaconazole. Serial brain imaging at 1 and 3 months, while on therapy, showed significant improvement. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  infection (neurology); infectious diseases

Mesh:

Substances:

Year:  2017        PMID: 28978601      PMCID: PMC5652351          DOI: 10.1136/bcr-2017-221473

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

Review 1.  Laboratory diagnosis of mucormycosis: current status and future perspectives.

Authors:  Michaela Lackner; Rita Caramalho; Cornelia Lass-Flörl
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

Review 2.  Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species.

Authors:  Marisa Z R Gomes; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

Review 3.  Epidemiology and outcome of zygomycosis: a review of 929 reported cases.

Authors:  Maureen M Roden; Theoklis E Zaoutis; Wendy L Buchanan; Tena A Knudsen; Tatyana A Sarkisova; Robert L Schaufele; Michael Sein; Tin Sein; Christine C Chiou; Jaclyn H Chu; Dimitrios P Kontoyiannis; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2005-07-29       Impact factor: 9.079

Review 4.  Histopathologic diagnosis of fungal infections in the 21st century.

Authors:  Jeannette Guarner; Mary E Brandt
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

Review 5.  Mucormycoses.

Authors:  Dimitrios Farmakiotis; Dimitrios P Kontoyiannis
Journal:  Infect Dis Clin North Am       Date:  2016-03       Impact factor: 5.982

6.  Cerebral zygomycosis.

Authors:  C Sundaram; A Mahadevan; V Laxmi; T C Yasha; V Santosh; J M K Murthy; A K Purohit; S Mohandas; S K Shankar
Journal:  Mycoses       Date:  2005-11       Impact factor: 4.377

Review 7.  [PCR-based diagnosis of mucormycosis in tissue samples].

Authors:  R Bialek; U E Zelck
Journal:  Pathologe       Date:  2013-11       Impact factor: 1.011

8.  Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis.

Authors:  Georgios Chamilos; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2008-08-15       Impact factor: 9.079

9.  Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF).

Authors:  L Millon; R Herbrecht; F Grenouillet; F Morio; A Alanio; V Letscher-Bru; S Cassaing; T Chouaki; C Kauffmann-Lacroix; P Poirier; D Toubas; O Augereau; S Rocchi; D Garcia-Hermoso; S Bretagne
Journal:  Clin Microbiol Infect       Date:  2015-12-17       Impact factor: 8.067

Review 10.  Cerebral mucormycosis associated with intravenous drug use: three case reports and review.

Authors:  R J Hopkins; M Rothman; A Fiore; S E Goldblum
Journal:  Clin Infect Dis       Date:  1994-12       Impact factor: 9.079

View more
  3 in total

Review 1.  Neuroinfections caused by fungi.

Authors:  Katarzyna Góralska; Joanna Blaszkowska; Magdalena Dzikowiec
Journal:  Infection       Date:  2018-05-21       Impact factor: 3.553

2.  Isolated cerebral mucormycosis masquerading as a tumor in an immunocompetent patient.

Authors:  Smita Chandra; Shubhi Sharma; Ruchir Vats; Sanjeev Pandey
Journal:  Autops Case Rep       Date:  2021-01-28

3.  Mucormycosis: An opportunistic pathogen during COVID-19.

Authors:  Iyer Mahalaxmi; Kaavya Jayaramayya; Dhivya Venkatesan; Mohana Devi Subramaniam; Kaviyarasi Renu; Padmavathi Vijayakumar; Arul Narayanasamy; Abilash Valsala Gopalakrishnan; Nachimuthu Senthil Kumar; Palanisamy Sivaprakash; Krothapalli R S Sambasiva Rao; Balachandar Vellingiri
Journal:  Environ Res       Date:  2021-07-06       Impact factor: 6.498

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.